First time in India, patient with dual cancer diagnosis, undergoes Robotic CRS with HIPEC
Chennai, May 16, 2024: Apollo Proton Cancer Centre (APCC), South Asia’s first and largest proton therapy announces the launch of the Robotic Surgery Programme for Ovarian Cancers and the successful completion of India’s First Robotic Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in two unique cases of advanced ovarian cancers. These medical milestones mark a significant advancement in the regional cancer treatment landscape, offering new hope and improved care standards for patients battling this severe illness.
Please find attached the press release and picture for your kind reference. We request you to kindly publish the same in your esteemed publication.
No comments:
Post a Comment